(Q36108794)

12 August 2017

1 reference

title

Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma (English)

1 reference

12 August 2017

main subject

head and neck carcinoma

1 reference

Susannah Jacob

2

0 references

Michael B. Barton

object named as

Michael Barton

series ordinal

3

0 references

Geoff P. Delaney

object named as

Geoff Delaney

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

103

1 reference

12 August 2017

issue

11

1 reference

12 August 2017

page(s)

2216-2227

1 reference

Parotid gland carcinoma: analysis of prognostic factors.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

The occult head and neck primary: to treat or not to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

How do we bring an acceptable level of radiotherapy services to a dispersed population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

A prospective survey of radiotherapy practice 2001 in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Does a centralized radiotherapy system provide adequate access to care?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Variations in the management and outcome of non-small cell lung cancer in Ontario

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

A model for decision making for the use of radiotherapy in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulva

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II--carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Use of radiotherapy in the primary treatment of cancer in South Australia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Floor of mouth carcinoma. The management of the clinically negative neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Outcome analysis for lip carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Carcinoma of major salivary glands. Recent trends

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Malignant salivary tumors--analysis of prognostic factors and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Surgical treatment of early oral carcinoma-results of a prospective controlled multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Rules of evidence and clinical recommendations on the use of antithrombotic agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21084

7 January 2021

Identifiers

DOI

10.1002/CNCR.21084

1 reference

12 August 2017

1 reference